HIV患者不应忽视癌症风险
Don't Overlook Cancer Risks in People With HIV, Experts Say
专家在IDWeek会议上指出,HIV患者应重视常见癌症的预防和筛查,特别是肺癌和消化道癌症风险较高。
专家强调HIV患者应重视常见癌症的预防和筛查,指出肺癌和消化道癌症的风险较高。
— Common cancers should be a key component of HIV care
November 11, 2026 • 3 min read
Preventing and screening for common cancers seen in the general population should be a key component of HIV care, experts said at the recent IDWeek annual meeting.
Given cancer risks, "prevention becomes a key part of HIV care," noted Ma Somsouk, MD, of the University of California San Francisco, during a presentation at the meeting. That includes smoking cessation, treating hepatitis B and hepatitis C infection, managing diabetes and metabolic dysfunction-associated steatohepatitis, and screening for cancer.
Of note, AIDS-related cancers, including Kaposi sarcoma and non-Hodgkin lymphoma, are on the decline with improved therapies, but remain more common among people with HIV compared with the general population.
According to a Swedish retrospective case-control study, people with HIV were significantly more likely to develop human papillomavirus (HPV)-associated anal, penile, vulvar, and cervical cancers. An observational study showed that rates of oropharyngeal cancer among people with HIV have increased since 2000, particularly among heterosexual men ages 50 and older.
Somsouk noted that "the cancer burden is shifting with age in the HIV population." An estimated 70% of all people with HIV are 45 and older, he said, with greater risks of non-AIDS-related cancers like lung and prostate cancer.
Lung Cancer
Research has shown that people living with HIV have an increased risk for lung cancer, with some studies estimating risk to be 1.5 to 3-fold higher compared with the general population.
Furthermore, in a study of Medicaid beneficiaries, HIV was associated with a higher incidence of lung cancer (HR 1.75, 95% CI 1.56-1.96), with Black women at particular risk (HR 2.48, 95% CI 2.09-2.95).
While declining lung cancer deaths in the U.S. are tied to lower smoking prevalence, smoking risk among people with HIV remains "astronomical," said Chyke Doubeni, MD, MPH, of the Ohio State University Wexner Medical Center in Columbus, at the IDWeek annual meeting.
A 2016 meta-analysis showed that while 20% of U.S. adults smoked, more than half of people with HIV (54%) smoked -- and that rate rose to 74% among those with HIV and injection drug use.
Lung cancer screening among those with HIV isn't a one-time visit, Doubeni noted. Instead, it's a process that includes prevention, detection, and follow-up care. For clinicians, documenting the smoking history of a patient with HIV is the crucial first step in the prevention process, he said, followed by directing patients to smoking cessation resources.
Understanding how screening recommendations may differ, and how to apply their criteria to patients is also important.
For anyone ages 50 to 80 years with a 20 pack-year smoking history who smokes or quit in the last 15 years, the U.S. Preventive Services Task Force (USPSTF) recommends annual lung cancer screening with low-dose CT. But Doubeni cautioned that many patients who die from lung cancer don't meet those criteria.
Recent American Cancer Society guidelines dropped the 15-year look-back and widened the potential screenable population. Why? "If you quit 20 years ago, your risk is lower, but it doesn't actually go away," Doubeni explained.
Gastrointestinal Cancers
People with HIV are at average risk for colorectal cancer and standard screening recommendations apply. In Somsouk's presentation at IDWeek, he recommended colorectal cancer screening at ages 45 to 75 for those with HIV, with any test recommended by the USPSTF.
"In general, the best test is the one that you can get your patient to complete," Somsouk noted. But patients who have a positive fecal immunochemical test need a colonoscopy within 6 months, he added.
As for other gastrointestinal cancers, Somsouk advised screening for esophageal cancer with upper endoscopy or a capsule test for HIV patients with chronic gastroesophageal reflux disease plus three or more risk factors. He also recommended Helicobacter pylori testing for those with dyspepsia, peptic ulcers, or a family history of gastric cancer, as well as in high-risk groups, including immigrants from high-incidence regions. For those with cirrhosis of any cause or chronic hepatitis B virus infection, he advised alpha-fetoprotein testing and ultrasound to screen for liver cancer.
来源:MedPage Today · medpagetoday.com